Linked e-resources

Details

Dasatinib induced pleural effusion and pulmonary hypertension
Ponatinib induced stroke
Nilotinib induced Peripheral Artery Occlusive Disease
Imatinib cardiotoxicity
Doxorubicin induced heart failure with reduced ejection fraction
Trastuzumab-related cardiotoxicity
Rituximab, Doxorubicin or cancer induced tachycardia
Carfilzomib (CFZ) induced heart failure with reduced ejection fraction
Immune checkpoint inhibitor cardiovascular toxicities
Androgen deprivation therapy cardiotoxicity
5 FU induced atrial fibrillation in the context of ischemic heart disease
Cisplatin induced acute coronary syndrome
Radiotherapy and valvular heart disease
Acute coronary syndrome in a patient with lung cancer 2 days after second cycle of carboplatin and Paclitaxel
Ibrutinib and cardiac arrythmias
Dual therapy BRAF inhibitor chemotherapy (dabrafenib +Trametinib chemotherapy) induced peripheral edema
Vascular endothelial growth factor (VEGF) Bevacizumab and hypertension
Amyloid heart disease
Venous thromboembolism in cancer patients
QT prolongation in cancer patients
Cardiovascular implantable electronic devices (CIEDs) in cancer patients needs radiation therapy
Atrial fibrillation in cancer patients
Pericardial disease in cancer patients
Large cardiac mass, an incidental finding in a patient with breast cancer.

Browse Subjects

Show more subjects...

Statistics

from
to
Export